Correlation Between Relay Therapeutics and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and Sana Biotechnology, you can compare the effects of market volatilities on Relay Therapeutics and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and Sana Biotechnology.
Diversification Opportunities for Relay Therapeutics and Sana Biotechnology
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Relay and Sana is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Relay Therapeutics and Sana Biotechnology
Given the investment horizon of 90 days Relay Therapeutics is expected to generate 0.59 times more return on investment than Sana Biotechnology. However, Relay Therapeutics is 1.68 times less risky than Sana Biotechnology. It trades about -0.33 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.38 per unit of risk. If you would invest 603.00 in Relay Therapeutics on August 29, 2024 and sell it today you would lose (127.00) from holding Relay Therapeutics or give up 21.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relay Therapeutics vs. Sana Biotechnology
Performance |
| Timeline |
| Relay Therapeutics |
| Sana Biotechnology |
Relay Therapeutics and Sana Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relay Therapeutics and Sana Biotechnology
The main advantage of trading using opposite Relay Therapeutics and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
| Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |